Microvascular Criteria

They connect observable vascular changes with consequences for tissue delivery. Reduced perfusion, altered vessel density or morphology, impaired endothelial function, and abnormal leakage can indicate that oxygen and nutrient delivery is disturbed. Interpreting these findings together helps clinicians and researchers relate small-vessel injury to organ dysfunction rather than evaluating vessel appearance in isolation.

The relevant findings span both structure and function. Vessel density and morphology describe physical changes, while perfusion reflects delivery through the tissue. Endothelial function indicates how effectively the vessel lining performs its regulatory role, and leakage signals loss of vascular containment. Considering these dimensions together provides a broader characterization than any single finding.

Standardization makes assessments more consistent between patients, institutions, and studies. Shared criteria support comparable disease characterization, staging, and monitoring, while reducing ambiguity when investigators evaluate treatment response or long-term risk. This common framework also helps researchers examine how microvascular dysfunction relates to organ injury and outcomes across different medical conditions.

Clinical findings can indicate the medical consequences of microvascular disease, imaging can characterize vessel-related structural or perfusion changes, and laboratory findings can provide measurable evidence of associated dysfunction. The overview does not assign one modality a universal priority. Instead, these sources can complement one another when clinicians assess disease presence, severity, progression, or response.

They are used to support diagnosis, staging, and monitoring when small-vessel disease affects organs or systemic health. Applications described in medicine include diabetic retinopathy, diabetic nephropathy, systemic inflammatory disorders, and peripheral vascular disease. Their use can help organize disease assessment over time and provide a basis for evaluating whether treatment is changing the vascular problem.

Microvascular criteria can contribute to risk stratification, treatment evaluation, and comparison of findings across clinical studies. By documenting changes in perfusion, vessel characteristics, endothelial function, or leakage, investigators can examine whether vascular abnormalities accompany organ injury or change during follow-up. This supports studies of long-term outcomes and the clinical significance of microvascular dysfunction.